Literature DB >> 9056485

Characterization of human lactoferrin produced in the baculovirus expression system.

V Salmon1, D Legrand, B Georges, M C Slomianny, B Coddeville, G Spik.   

Abstract

Lactoferrin, an iron-binding 80-kDa glycoprotein, is a major component of human milk whose structure is now well defined. The binding site of lactoferrin to the membrane receptor of lymphocyte has been located in the region 4-52, but the amino acids directly involved in the interaction have not been identified yet. To gain further insights into the structure-function relationships of the lactoferrin binding site, we first expressed the cDNA encoding human lactoferrin in the lepidoptera Spodoptera frugiperda cells (Sf9) using a recombinant baculovirus. The selected transformant secreted and N-glycosylated protein of 78 kDa which was immunoprecipitated by specific anti-lactoferrin antibodies. To confirm the structure and the function of the recombinant lactoferrin, the protein was purified by ion-exchange chromatography and its physical, biochemical, and biological properties were compared with those of the native protein. In particular, the N-terminal amino acid sequence and the iron-binding stability as a function of pH, of both proteins, were identical. The main difference concerns the glycosylation which leads to glycans of lower molecular masses as detected by the electrophoretic mobility of lactoferrin after N-glycosidase F treatment and matrix-assisted laser desorption ionization/time-of-flight mass spectrometry. Despite the different glycosylation features, the recombinant lactoferrin retained the binding property to the Jurkat human lymphoblastic T-cell line of the native lactoferrin. On the basis of these analyses, production of protein mutants generated by site-directed mutagenesis is now in process.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9056485     DOI: 10.1006/prep.1996.0687

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  10 in total

1.  The N-terminal Arg2, Arg3 and Arg4 of human lactoferrin interact with sulphated molecules but not with the receptor present on Jurkat human lymphoblastic T-cells.

Authors:  D Legrand; P H van Berkel; V Salmon; H A van Veen; M C Slomianny; J H Nuijens; G Spik
Journal:  Biochem J       Date:  1997-11-01       Impact factor: 3.857

Review 2.  Glycoproteins from insect cells: sialylated or not?

Authors:  I Marchal; D L Jarvis; R Cacan; A Verbert
Journal:  Biol Chem       Date:  2001-02       Impact factor: 3.915

3.  Lactoferrin inhibits the endotoxin interaction with CD14 by competition with the lipopolysaccharide-binding protein.

Authors:  E Elass-Rochard; D Legrand; V Salmon; A Roseanu; M Trif; P S Tobias; J Mazurier; G Spik
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

4.  The N1 domain of human lactoferrin is required for internalization by caco-2 cells and targeting to the nucleus.

Authors:  Yasushi A Suzuki; Henry Wong; Kin-Ya Ashida; Anthony B Schryvers; Bo Lönnerdal
Journal:  Biochemistry       Date:  2008-09-12       Impact factor: 3.162

5.  One of two human lactoferrin variants exhibits increased antibacterial and transcriptional activation activities and is associated with localized juvenile periodontitis.

Authors:  Kabilan Velliyagounder; Jeffrey B Kaplan; David Furgang; Diana Legarda; Gill Diamond; Ruth E Parkin; Daniel H Fine
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

6.  A high-throughput method for the quantification of iron saturation in lactoferrin preparations.

Authors:  Grzegorz Majka; Klaudyna Śpiewak; Katarzyna Kurpiewska; Piotr Heczko; Grażyna Stochel; Magdalena Strus; Małgorzata Brindell
Journal:  Anal Bioanal Chem       Date:  2013-04-21       Impact factor: 4.142

7.  N-glycosylation potential of maize: the human lactoferrin used as a model.

Authors:  B Samyn-Petit; V Gruber; C Flahaut; J P Wajda-Dubos; S Farrer; A Pons; G Desmaizieres; M C Slomianny; M Theisen; P Delannoy
Journal:  Glycoconj J       Date:  2001-07       Impact factor: 2.916

8.  Generation of five human lactoferrin transgenic cloned goats using fibroblast cells and their methylation status of putative differential methylation regions of IGF2R and H19 imprinted genes.

Authors:  Li Meng; Yongjie Wan; Yanyan Sun; Yanli Zhang; Ziyu Wang; Yang Song; Feng Wang
Journal:  PLoS One       Date:  2013-10-30       Impact factor: 3.240

9.  Large-scale production of recombinant human lactoferrin from high-expression, marker-free transgenic cloned cows.

Authors:  Ming Wang; Zhaolin Sun; Tian Yu; Fangrong Ding; Ling Li; Xi Wang; Mingbo Fu; Haiping Wang; Jinming Huang; Ning Li; Yunping Dai
Journal:  Sci Rep       Date:  2017-09-06       Impact factor: 4.379

10.  Lactoferrin inhibits the lipopolysaccharide-induced expression and proteoglycan-binding ability of interleukin-8 in human endothelial cells.

Authors:  Elisabeth Elass; Maryse Masson; Joël Mazurier; Dominique Legrand
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.